Roger Brian Cole-Baker
Director/Board Member at Lypanosys Pte Ltd.
Profile
Roger Brian Cole-Baker is currently a Director at Lypanosys Pte Ltd., a Member at the New Zealand Institute of Chartered Accountants, and a Trustee at Parnell Trust.
He was formerly a Director at Lypanosys (NZ) Ltd.
He obtained an undergraduate degree from Auckland University.
Roger Brian Cole-Baker active positions
Companies | Position | Start |
---|---|---|
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Director/Board Member | 2011-06-05 |
New Zealand Institute of Chartered Accountants
New Zealand Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services New Zealand Institute of Chartered Accountants operates as an institute of chartered accountants. The company is headquartered in Wellington, New Zealand. | Corporate Officer/Principal | 2011-06-05 |
Parnell Trust | Director/Board Member | - |
Former positions of Roger Brian Cole-Baker
Companies | Position | End |
---|---|---|
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Director/Board Member | - |
Training of Roger Brian Cole-Baker
Auckland University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
New Zealand Institute of Chartered Accountants
New Zealand Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services New Zealand Institute of Chartered Accountants operates as an institute of chartered accountants. The company is headquartered in Wellington, New Zealand. | Commercial Services |
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Health Technology |
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
Parnell Trust |
- Stock Market
- Insiders
- Roger Brian Cole-Baker